Modular nanoarray vaccine for SARS-CoV-2

被引：0

作者：

Zagorski, Karen ^{[1
]}

Pandey, Kabita ^{[2
,3
]}

Rajaiah, Rajesh ^{[2
]}

Olwenyi, Omalla A. ^{[2
,3
]}

Bade, Aditya N. ^{[2
]}

Acharya, Arpan ^{[2
]}

Johnston, Morgan ^{[2
]}

Filliaux, Shaun ^{[1
]}

Lyubchenko, Yuri L. ^{[1
]}

Byrareddy, Siddappa N. ^{[2
,3
,4
,5
,6
]}

机构：

[1] Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha,NE,68198-6025, United States

[2] Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha,NE, United States

[3] Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha,NE, United States

[4] Department of Genetics, Cell Biology, and Anatomy, University of Nebraska Medical Center, Omaha,NE, United States

[5] Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha,NE, United States

[6] Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden

来源：

Nanomedicine: Nanotechnology, Biology, and Medicine | 2022年 / 46卷

关键词：

Compendex;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Coronavirus

引用

下载

共 50 条

[21] Effectiveness of an Inactivated SARS-CoV-2 Vaccine
Wilder-Smith, Annelies
Mulholland, Kim
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (10): : 946 - 948
[22] Vaccine safety - is the SARS-CoV-2 vaccine any different?
Tau, Noam
Yahav, Dafna
Shepshelovich, Daniel
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (05) : 1322 - 1325
[23] Heterologous SARS-CoV-2 booster vaccine for individuals with hematological malignancies after a primary SARS-CoV-2 mRNA vaccine series
Sherman, Amy C.
van Haren, Simon D.
Borberg, Ella
Swank, Zoe
Aleissa, Muneerah
Tong, Alexandra
Rooks, Rebecca
Kanwal, Urwah
Levine, Hannah
Yates, Bridget
Izaguirre, Natalie
Ryff, Kevin
Thomas, Sanya
Parisi, Lindsey
Li, Xiaofang
Walt, David R.
Levy, Ofer
Walsh, Stephen R.
Issa, Nicolas C.
Baden, Lindsey R.
VACCINE, 2024, 42 (22)
[24] Fluctuations of SARS-CoV-2 Antibody Concentrations with Age in Vaccine Naive Population with SARS-CoV-2 Infection
Akinyemi, A.
Wantuch, A.
Errath, A.
Manjee, K.
Benirschke, R. C.
Lee, H.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2022, 158 (SUPP 1) : S138 - S139
[25] Immunoinformatic construction of an adenovirus-based modular vaccine platform and its application in the design of a SARS-CoV-2 vaccine
Porto, Pedro Soares
Anjos, Deborah
Dabilla, Nathania
da Fonseca, Simone Goncalves
Souza, Menira
INFECTION GENETICS AND EVOLUTION, 2020, 85
[26] HIV and SARS-CoV-2 Pathogenesis and Vaccine Development
Fleury, Herve
VIRUSES-BASEL, 2022, 14 (12):
[27] Development of an inactivated vaccine candidate for SARS-CoV-2
Gao, Qiang
Bao, Linlin
Mao, Haiyan
Wang, Lin
Xu, Kangwei
Yang, Minnan
Li, Yajing
Zhu, Ling
Wang, Nan
Lv, Zhe
Gao, Hong
Ge, Xiaoqin
Kan, Biao
Hu, Yaling
Liu, Jiangning
Cai, Fang
Jiang, Deyu
Yin, Yanhui
Qin, Chengfeng
Li, Jing
Gong, Xuejie
Lou, Xiuyu
Shi, Wen
Wu, Dongdong
Zhang, Hengming
Zhu, Lang
Deng, Wei
Li, Yurong
Lu, Jinxing
Li, Changgui
Wang, Xiangxi
Yin, Weidong
Zhang, Yanjun
Qin, Chuan
SCIENCE, 2020, 369 (6499) : 77 - +
[28] SARS-CoV-2 vaccine as a potential trigger for narcolepsy
Mungmunpuntipantip, Rujittika
Wiwanitkit, Viroj
JOURNAL OF CLINICAL SLEEP MEDICINE, 2022, 18 (10): : 2519 - 2519
[29] A systematic review of SARS-CoV-2 vaccine candidates
Dong, Yetian
Dai, Tong
Wei, Yujun
Zhang, Long
Zheng, Min
Zhou, Fangfang
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2020, 5 (01)
[30] Adapting Serosurveys for the SARS-CoV-2 Vaccine Era
Duarte, Nathan
Yanes-Lane, Mercedes
Arora, Rahul K.
Bobrovitz, Niklas
Liu, Michael
Bego, Mariana G.
Yan, Tingting
Cao, Christian
Gurry, Celine
Hankins, Catherine A.
Cheng, Matthew Pellan
Gingras, Anne-Claude
Mazer, Bruce D.
Papenburg, Jesse
Langlois, Marc-Andre
OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (02):

← 1 2 3 4 5 →